Dual biological treatments in immune-mediated disorders: a single center experience

Dual biological treatments in immune-mediated disorders: a single center experience

Abstract Background Physicians may encounter situations where they need to co-administer omalizumab with non–IgE-targeting monoclonal antibodies. In this study, we share our experience with these dual biologic treatments. Objective To evaluate the efficacy and safety of dual biological therapy using...

Full description

Saved in:
Bibliographic Details
Main Authors: Oded Shamriz, Elchanan Parnasa, Limor Rubin, Aviv Talmon, Yaarit Ribak, Isaam Hindi, Hagit Peleg, Ronit Confino-Cohen, Yuval Tal
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Immunology
Subjects:
Omalizumab
Biologics
Dual biologics
IgE
Biotherapy
Online Access:https://doi.org/10.1186/s12865-025-00705-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12865-025-00705-8

Similar Items